| 2021 |
Liver and cardiovascular mortality after hepatitis C virus eradication by DAA: Data from RESIST-HCV cohort |
Articolo in rivista |
Vai |
| 2021 |
PNPLA3 and TLL-1 Polymorphisms as Potential Predictors of Disease Severity in Patients With COVID-19 |
Articolo in rivista |
Vai |
| 2021 |
Interplay between non-alcoholic fatty liver disease and cardiovascular risk in an asymptomatic general population |
Articolo in rivista |
Vai |
| 2020 |
Genetic susceptibility of increased intestinal permeability is associated with progressive liver disease and diabetes in patients with non-alcoholic fatty liver disease |
Articolo in rivista |
Vai |
| 2020 |
FibroScan Identifies Patients With Nonalcoholic Fatty Liver Disease and Cardiovascular Damage |
Articolo in rivista |
Vai |
| 2020 |
Extrahepatic Manifestations of Chronic Viral C Hepatitis |
Review essay (rassegna critica) |
Vai |
| 2020 |
Reduced incidence of type 2 diabetes in patients with chronic hepatitis C virus infection cleared by direct-acting antiviral therapy: A prospective study |
Articolo in rivista |
Vai |
| 2020 |
Optimization of hepatitis C virus screening strategies by birth cohort in Italy |
Articolo in rivista |
Vai |
| 2020 |
Progression-Free Survival Early Assessment Is a Robust Surrogate Endpoint of Overall Survival in Immunotherapy Trials of Hepatocellular Carcinoma |
Articolo in rivista |
Vai |
| 2020 |
Lean NAFLD: A Distinct Entity Shaped by Differential Metabolic Adaptation |
Articolo in rivista |
Vai |
| 2020 |
SARS-CoV-2 Viral Load, IFNλ Polymorphisms and the Course of COVID-19: An Observational Study |
Articolo in rivista |
Vai |
| 2020 |
Monitoring Occurrence of Liver-Related Events and Survival by Transient Elastography in Patients With Nonalcoholic Fatty Liver Disease and Compensated Advanced Chronic Liver disease |
Articolo in rivista |
Vai |
| 2020 |
Hepatitis C virus eradication by direct antiviral agents abates oxidative stress in patients with advanced liver fibrosis |
Articolo in rivista |
Vai |
| 2020 |
Genetic variation in the TLL1 gene is not associated with fibrosis in patients with metabolic associated fatty liver disease |
Articolo in rivista |
Vai |
| 2020 |
Hepatic benefits of HCV cure |
Articolo in rivista |
Vai |
| 2020 |
Impact of hepatitis C virus clearance by direct-acting antiviral treatment on the incidence of major cardiovascular events: A prospective multicentre study |
Articolo in rivista |
Vai |
| 2020 |
Association Between PNPLA3 rs738409 C>G Variant and Liver-Related Outcomes in Patients with Non-alcoholic Fatty Liver Disease |
Articolo in rivista |
Vai |
| 2020 |
Metabolic comorbidities and male sex influence steatosis in chronic hepatitis C after viral eradication by direct-acting antiviral therapy (DAAs): Evaluation by the controlled attenuation parameter (CAP) |
Articolo in rivista |
Vai |
| 2020 |
PNPLA3 rs738409 C>G Variant Predicts Fibrosis Progression by Noninvasive Tools in Nonalcoholic Fatty Liver Disease |
Articolo in rivista |
Vai |
| 2019 |
Aminopyrine breath test predicts liver-related events and death in HCV-related cirrhosis on SVR after DAA therapy |
Articolo in rivista |
Vai |
| 2019 |
Serum coding and non-coding RNAs as biomarkers of NAFLD and fibrosis severity |
Articolo in rivista |
Vai |
| 2019 |
Point-of-care HCV RNA testing in the setting of DAA therapy: HCV-FiS (HEpatitis C Virus Fingerstick Study) |
Articolo in rivista |
Vai |
| 2019 |
Is Transient Elastography Needed for Noninvasive Assessment of High-Risk Varices? the REAL Experience |
Articolo in rivista |
Vai |
| 2019 |
Prevalence and Risk Factors of Significant Fibrosis in Patients With Nonalcoholic Fatty Liver Without Steatohepatitis |
Articolo in rivista |
Vai |
| 2019 |
Direct acting antivirals after successful treatment of early hepatocellular carcinoma improve survival in HCV-cirrhotic patients |
Abstract in atti di convegno pubblicato in rivista |
Vai |
| 2019 |
Current and
forthcoming perspectives in linkage to care of hepatitis C virus
infection:
Assessment of an Italian focus group. |
Articolo in rivista |
Vai |
| 2019 |
Evaluating the association of serum ferritin and hepatic iron with disease severity in non-alcoholic fatty liver disease |
Articolo in rivista |
Vai |
| 2019 |
AISF position paper on HCV in immunocompromised patients |
Articolo in rivista |
Vai |
| 2019 |
Update of the statements on biology and clinical impact of occult hepatitis B virus infection |
Articolo in rivista |
Vai |
| 2019 |
NS5A Gene Analysis by Next Generation Sequencing in HCV Nosocomial Transmission Clusters of HCV Genotype 1b Infected Patients |
Articolo in rivista |
Vai |
| 2019 |
Direct-acting antivirals after successful treatment of early hepatocellular carcinoma improve survival in HCV-cirrhotic patients |
Articolo in rivista |
Vai |
| 2019 |
Current epidemiology of HCV in Sicily: the RESIST-HCV model |
Abstract in atti di convegno pubblicato in rivista |
Vai |
| 2019 |
Add-on peginterferon alfa-2a to nucleos(t)ide analogue therapy for Caucasian patients with hepatitis B 'e' antigen-negative chronic hepatitis B genotype D. |
Articolo in rivista |
Vai |
| 2019 |
Resistance test guided retreatment of HCV infected patients with a previous failure to a NS5A inhibitor-containing regimen: the Italian Vironet C real life experience |
Proceedings (TIPOLOGIA NON ATTIVA) |
Vai |
| 2019 |
Optimizing patient referral and center capacity in the management of chronic hepatitis C: Lessons from the Italian experience |
Articolo in rivista |
Vai |
| 2019 |
Economic Consequences of Investing in Anti-HCV Antiviral Treatment from the Italian NHS Perspective: A Real-World-Based Analysis of PITER Data |
Articolo in rivista |
Vai |
| 2019 |
Daclatasvir-based regimens in HCV cirrhosis: experience from the Italian early access program. |
Articolo in rivista |
Vai |
| 2019 |
IMPACT OF NON-ALCOHOLIC FATTY LIVER DISEASE ON CARDIOVASCULAR RISK IN A GENERAL POPULATION |
Abstract in atti di convegno pubblicato in rivista |
Vai |
| 2019 |
Impact of Obesity and Alanine Aminotransferase Levels on the Diagnostic Accuracy for Advanced Liver Fibrosis of Noninvasive Tools in Patients with Nonalcoholic Fatty Liver Disease |
Articolo in rivista |
Vai |
| 2018 |
Corrigendum to “Premature ovarian senescence and a high miscarriage rate impair fertility in women with HCV” [J Hepatol 68 (2018) 33–41](S0168827817322596)(10.1016/j.jhep.2017.08.019) |
Nota o commento |
Vai |
| 2018 |
Hepatitis C: The beginning of the end-key elements for successful European and national strategies to eliminate HCV in Europe. |
Articolo in rivista |
Vai |
| 2018 |
Subclinical cardiovascular damage in patients with HCV cirrhosis before and after treatment with direct antiviral agents: a prospective study |
Articolo in rivista |
Vai |
| 2018 |
Expert opinion on managing chronic HCV in patients with cardiovascular disease |
Articolo in rivista |
Vai |
| 2018 |
Non-invasive prediction of esophageal varices by stiffness and platelet in non-alcoholic fatty liver disease cirrhosis |
Articolo in rivista |
Vai |
| 2018 |
Frequent NS5A and multiclass resistance in almost all HCV genotypes at DAA failures: What are the chances for second-line regimens? |
Lettera |
Vai |
| 2018 |
The course of oesophagogastric varices in patients with cirrhosis after DAA-induced HCV clearance |
Abstract in atti di convegno pubblicato in rivista |
Vai |
| 2018 |
Incidence of Hepatocellular Carcinoma in Patients With HCV-Associated Cirrhosis Treated With Direct-Acting Antiviral Agents |
Articolo in rivista |
Vai |
| 2018 |
Safety and efficacy of ombitasvir/paritaprevir/ritonavir/dasabuvir plus ribavirin in patients over 65 years with HCV genotype 1 cirrhosis |
Articolo in rivista |
Vai |
| 2018 |
Incidence of Hepatocellular Carcinoma in Patients With HCV-Associated Cirrhosis Treated With Direct-Acting Antiviral Agents |
Articolo in rivista |
Vai |
| 2018 |
Prevalence and severity of nonalcoholic fatty liver disease by transient elastography: Genetic and metabolic risk factors in a general population |
Articolo in rivista |
Vai |
| 2018 |
Is global elimination of HCV realistic? |
Articolo in rivista |
Vai |
| 2018 |
Hepatitis C Virus Eradication by Direct Antiviral Agents Improves Carotid Atherosclerosis in patients with Severe Liver Fibrosis |
Articolo in rivista |
Vai |
| 2018 |
Reactive hyperemia index (RHI) and cognitive performance indexes are associated with histologic markers of liver disease in subjects with non-alcoholic fatty liver disease (NAFLD): a case control study. |
Articolo in rivista |
Vai |
| 2018 |
Forecasting Hepatitis C liver disease burden on real-life data. Does the hidden iceberg matter to reach the elimination goals? |
Articolo in rivista |
Vai |
| 2018 |
Disease outcomes after DAA-induced SVR: Data from the resist-HCV cohort |
Poster pubblicato in rivista |
Vai |
| 2018 |
Optimising management of patients with hepatitis C virus in the age of direct-acting antivirals: results of a Delphi consensus. |
Articolo in rivista |
Vai |
| 2018 |
Sofosbuvir plus daclatasvir with or without ribavirin is safe and effective for post-transplant hepatitis C recurrence and severe fibrosis and cirrhosis: A prospective study |
Articolo in rivista |
Vai |
| 2018 |
Global prevalence, treatment, and prevention of hepatitis B virus infection in 2016: a modelling study. |
Articolo in rivista |
Vai |
| 2018 |
L’insulino-resistenza è il principale fattore indipendente correlato con l’aumentato rischio metabolico nelle donne affette da PCOS |
Proceedings (TIPOLOGIA NON ATTIVA) |
Vai |
| 2018 |
Real life experiences in HCV management in 2018 |
Articolo in rivista |
Vai |
| 2018 |
Causal relationship of hepatic fat with liver damage and insulin resistance in nonalcoholic fatty liver |
Articolo in rivista |
Vai |
| 2018 |
Should we cure hepatitis C virus in patients with hepatocellular carcinoma while treating cancer? |
Articolo in rivista |
Vai |
| 2018 |
Viral resistance in HCV infection. |
Articolo in rivista |
Vai |
| 2018 |
Prevalence of Single and Multiple Natural NS3, NS5A and NS5B Resistance-Associated Substitutions in Hepatitis C Virus Genotypes 1-4 in Italy. |
Articolo in rivista |
Vai |
| 2018 |
Modeling NAFLD disease burden in China, France, Germany, Italy, Japan, Spain, United Kingdom, and United States for the period 2016–2030 |
Articolo in rivista |
Vai |
| 2018 |
HBV reactivation in patients with HCV/HBV cirrhosis on treatment with direct-acting antivirals |
Articolo in rivista |
Vai |
| 2017 |
Interferon lambda 4 rs368234815 TT>δG variant is associated with liver damage in patients with nonalcoholic fatty liver disease |
Articolo in rivista |
Vai |
| 2017 |
Modeling cost-effectiveness and health gains of a "universal" versus "prioritized" hepatitis C virus treatment policy in a real-life cohort. |
Articolo in rivista |
Vai |
| 2017 |
Usefulness of the index of NASH - ION for the diagnosis of steatohepatitis in patients with non-alcoholic fatty liver: An external validation study |
Articolo in rivista |
Vai |
| 2017 |
Telomerase reverse transcriptase germline mutations and hepatocellular carcinoma in patients with nonalcoholic fatty liver disease |
Articolo in rivista |
Vai |
| 2017 |
Validity criteria for the diagnosis of fatty liver by M probe-based controlled attenuation parameter |
Articolo in rivista |
Vai |
| 2017 |
Insulin resistance and hyperandrogenism drive steatosis and fibrosis risk in young females with PCOS |
Articolo in rivista |
Vai |
| 2017 |
Efficacy of a 12-week simeprevir plus peginterferon/ribavirin (PR) regimen in treatment-naïve patients with hepatitis C virus (HCV) genotype 4 (GT4) infection and mild-to-moderate fibrosis displaying early on-treatment virologic response |
Articolo in rivista |
Vai |
| 2017 |
Serial combination of non-invasive tools improves the diagnostic accuracy of severe liver fibrosis in patients with NAFLD |
Articolo in rivista |
Vai |
| 2017 |
Liver and Cardiovascular Damage in Patients With Lean Nonalcoholic Fatty Liver Disease, and Association With Visceral Obesity |
Articolo in rivista |
Vai |
| 2017 |
A meta-analysis of single HCV-untreated arm of studies evaluating outcomes after curative treatments of HCV-related hepatocellular carcinoma |
Articolo in rivista |
Vai |
| 2017 |
Sarcopenia is associated with severe liver fibrosis in patients with non-alcoholic fatty liver disease |
Articolo in rivista |
Vai |
| 2017 |
Hepatic decompensation is the major driver of death in HCV-infected cirrhotic patients with successfully treated early hepatocellular carcinoma |
Articolo in rivista |
Vai |
| 2017 |
Treatment of Hepatitis C virus infection in Italy: A consensus report from an expert panel |
Articolo in rivista |
Vai |
| 2017 |
Metabolic syndrome and severity of fibrosis in nonalcoholic fatty liver disease: An age-dependent risk profiling study |
Articolo in rivista |
Vai |
| 2017 |
Primary Biliary Cholangitis: advances in management and treatment of the disease |
Articolo in rivista |
Vai |
| 2017 |
Between reality and the guidelines: A survey on perception, diagnosis and management of hepatic encephalopathy in 201 Italian specialist centres |
Articolo in rivista |
Vai |
| 2017 |
Real-world effectiveness of ombitasvir/paritaprevir/ritonavir±dasabuvir±ribavirin in patients with hepatitis C virus genotype 1 or 4 infection: A meta-analysis |
Abstract in rivista |
Vai |
| 2017 |
Hepatitis C virus prevalence and level of intervention required to achieve the WHO targets for elimination in the European Union by 2030: a modelling study |
Articolo in rivista |
Vai |
| 2017 |
A focus on epidemiology of drug-induced liver injury: analysis of a prospective cohort |
Articolo in rivista |
Vai |
| 2017 |
MBOAT7 rs641738 variant and hepatocellular carcinoma in non-cirrhotic individuals |
Articolo in rivista |
Vai |
| 2017 |
Current and future challenges in HCV: insights from an Italian experts panel |
Articolo in rivista |
Vai |
| 2017 |
Improved noninvasive prediction of liver fibrosis by liver stiffness measurement in patients with nonalcoholic fatty liver disease accounting for controlled attenuation parameter values |
Articolo in rivista |
Vai |
| 2017 |
Improvement of ALT decay kinetics by all-oral HCV treatment: Role of NS5A inhibitors and differences with IFN-based regimens |
Articolo in rivista |
Vai |
| 2017 |
HBV recurrence after HCV clearance on DAAs: Sometimes they come back |
Nota o commento |
Vai |
| 2017 |
A Randomized, Placebo-Controlled Trial of Cenicriviroc for Treatment of Nonalcoholic Steatohepatitis with Fibrosis |
Articolo in rivista |
Vai |
| 2017 |
Hepatocellular carcinoma and direct-acting antivirals: A never ending story? |
Articolo in rivista |
Vai |
| 2017 |
Alexithymia and personality traits of patients with inflammatory bowel disease |
Articolo in rivista |
Vai |
| 2017 |
Hepatocellular carcinoma recurrence in patients with curative resection or ablation: impact of HCV eradication does not depend on the use of interferon |
Articolo in rivista |
Vai |
| 2017 |
Premature ovarian senescence and a high miscarriage rate impair fertility in women with HCV |
Articolo in rivista |
Vai |
| 2017 |
Ombitasvir, paritaprevir, and ritonavir, with or without dasabuvir, plus ribavirin for patients with hepatitis C virus genotype 1 or 4 infection with cirrhosis (ABACUS): a prospective observational study |
Articolo in rivista |
Vai |
| 2017 |
Global prevalence and genotype distribution of hepatitis C virus infection in 2015: A modelling study |
Articolo in rivista |
Vai |
| 2017 |
Fibronectin type III domain-containing protein 5 rs3480 A>G polymorphism, irisin, and liver fibrosis in patients with Nonalcoholic fatty liver disease |
Articolo in rivista |
Vai |
| 2017 |
Impact of obesity, insulin resistance and hyperandrogenism on steatosis and fibrosis risk in young females with PCOS |
Proceedings (TIPOLOGIA NON ATTIVA) |
Vai |
| 2017 |
Can we prevent and modify cardiometabolic disorders by controlling HCV infection? |
Articolo in rivista |
Vai |
| 2016 |
Hepatitis C Virus Infection Is Associated With Increased Cardiovascular Mortality: A Meta-Analysis of Observational Studies |
Articolo in rivista |
Vai |
| 2016 |
Reply |
Lettera |
Vai |
| 2016 |
The MBOAT7-TMC4 Variant rs641738 Increases Risk of Nonalcoholic Fatty Liver Disease in Individuals of European Descent |
Articolo in rivista |
Vai |
| 2016 |
Renin-angiotensin system inhibitors, type 2 diabetes and fibrosis progression: An observational study in patients with nonalcoholic fatty liver disease |
Articolo in rivista |
Vai |
| 2016 |
Effects of Eradicating Hepatitis C Virus Infection in Patients With Cirrhosis Differ With Stage of Portal Hypertension |
Articolo in rivista |
Vai |
| 2016 |
Impact of virus eradication in patients with compensated hepatitis C virus-related cirrhosis: competing risks and multistate model |
Articolo in rivista |
Vai |
| 2016 |
From current status to optimization of HCV treatment: Recommendations from an expert panel |
Articolo in rivista |
Vai |
| 2016 |
Survival of patients with HCV cirrhosis and sustained virologic response is similar to the general population. |
Articolo in rivista |
Vai |
| 2016 |
Increased expression of markers of early atherosclerosis in patients with inflammatory bowel disease |
Articolo in rivista |
Vai |
| 2016 |
IFNL3/4 genotype is associated with altered immune cell populations in peripheral blood in chronic hepatitis C infection |
Articolo in rivista |
Vai |
| 2016 |
Direct antiviral agents and risk for HCC early recurrence: Much ado about nothing |
Lettera |
Vai |
| 2016 |
Impact of safety-related dose reductions or discontinuations on sustained virologic response in HCV-infected patients: Results from the GUARD-C Cohort |
Articolo in rivista |
Vai |
| 2016 |
The presence of white matter lesions is associated with the fibrosis severity of nonalcoholic fatty liver disease |
Articolo in rivista |
Vai |
| 2016 |
TM6SF2 rs58542926 is not associated with steatosis and fibrosis in largecohort of patients with genotype 1 chronic hepatitis C |
Articolo in rivista |
Vai |
| 2016 |
Clinical course and genetic susceptibility of primary biliary cirrhosis: Analysis of a prospective cohort |
Articolo in rivista |
Vai |
| 2016 |
Six year adalimumab efficacy in steroid-dependent Crohn's disease patients: A prospective single-center real life study |
Recensione in rivista |
Vai |
| 2016 |
An open-label trial of 12-week simeprevir plus Peginterferon/Ribavirin (PR) in treatment-naïve patients with Hepatitis C Virus (HCV) Genotype 1 (GT1) |
Articolo in rivista |
Vai |
| 2016 |
Why do I treat my patients with mild hepatitis C? |
Articolo in rivista |
Vai |
| 2016 |
Reply |
Lettera |
Vai |
| 2016 |
Elafibranor, an Agonist of the Peroxisome Proliferator-Activated Receptor-α and -δ, Induces Resolution of Nonalcoholic Steatohepatitis Without Fibrosis Worsening |
Articolo in rivista |
Vai |
| 2015 |
Randomised clinical trial: Alisporivir combined with peginterferon and ribavirin in treatment-naïve patients with chronic HCV genotype 1 infection (ESSENTIAL II) |
Articolo in rivista |
Vai |
| 2015 |
Epicardial fat in patients with non-alcoholic fatty liver disease |
Lettera |
Vai |
| 2015 |
The combination of liver stiffness measurement and NAFLD fibrosis score improves the noninvasive diagnostic accuracy for severe liver fibrosis in patients with nonalcoholic fatty liver disease. |
Articolo in rivista |
Vai |
| 2015 |
Residual risk of hepatocellular carcinoma after HCV eradication: more than meets the eye. |
Review essay (rassegna critica) |
Vai |
| 2015 |
Epicardial Fat, Cardiac Geometry and Cardiac Function in Patients with Nonalcoholic Fatty Liver Disease: Association with the Severity of Liver Disease |
Articolo in rivista |
Vai |
| 2015 |
Ovarian senescence increases liver fibrosis in humans and zebrafish with steatosis |
Articolo in rivista |
Vai |
| 2015 |
The presence of White Matter Lesions is not associated with Non-alcoholic Fatty Liver Disease but with its histological severity |
Abstract in rivista |
Vai |
| 2015 |
Quantification of fibrosis by collagen proportionate area predicts hepatic decompensation in hepatitis C cirrhosis |
Articolo in rivista |
Vai |
| 2015 |
Predictors of survival in patients with advanced hepatocellular carcinoma who permanently discontinued sorafenib |
Articolo in rivista |
Vai |
| 2015 |
Tumor Necrosis Factor Alpha Antagonists and Occurrence of Autoantibodies in Inflammatory Bowel Disease Patients: A Single Center Experience |
Articolo in rivista |
Vai |
| 2015 |
The severity of steatosis influences liver stiffness measurement in patients with nonalcoholic fatty liver disease |
Articolo in rivista |
Vai |
| 2015 |
Undetectable HCV-RNA at treatment-week 8 results in high-sustained virological response in HCV G1 treatment-experienced patients with advanced liver disease: The International Italian/Spanish Boceprevir/Peginterferon/Ribavirin Name Patients Program |
Articolo in rivista |
Vai |
| 2015 |
HCV: The best cure possible or the best possible cure? |
Nota o commento |
Vai |
| 2015 |
Impact of HBV genotypes A and D genetic variability on infection evolution |
Articolo in rivista |
Vai |
| 2015 |
Transmembrane 6 Superfamily Member 2 Gene Variant Disentangles Nonalcoholic Steatohepatitis From Cardiovascular Disease |
Articolo in rivista |
Vai |
| 2015 |
PNPLA3 rs738409 I748M is associated with steatohepatitis in 434 non-obese subjects with hepatitis C |
Articolo in rivista |
Vai |
| 2015 |
MERTK rs4374383 polymorphism affects the severity of fibrosis in nonalcoholic fatty liver disease |
Articolo in rivista |
Vai |
| 2015 |
Ramucirumab versus placebo as second-line treatment in patients with advanced hepatocellular carcinoma following first-line therapy with sorafenib (REACH): A randomised, double-blind, multicentre, phase 3 trial |
Articolo in rivista |
Vai |
| 2015 |
Obstructive Sleep Apnea Is Associated with Liver Damage and Atherosclerosis in Patients with Non-Alcoholic Fatty Liver Disease |
Articolo in rivista |
Vai |
| 2015 |
Refining sorafenib therapy: Lessons from clinical practice |
Articolo in rivista |
Vai |
| 2015 |
Cost-effectiveness of sofosbuvir plus ribavirin with or without pegylated interferon for the treatment of chronic hepatitis C in Italy |
Articolo in rivista |
Vai |
| 2015 |
The rs2294918 E434K variant modulates PNPLA3 expression and liver damage |
Articolo in rivista |
Vai |
| 2015 |
Extra-hepatic Morbidity and Mortality of Chronic Hepatitis C |
Articolo in rivista |
Vai |
| 2015 |
Clinical course and management of acute and chronic viral hepatitis during pregnancy. |
Review essay (rassegna critica) |
Vai |
| 2015 |
Current and future HCV therapy: Do we still need other anti-HCV drugs? |
Articolo in rivista |
Vai |
| 2015 |
The Hepatic Expression of Vitamin D Receptor is Inversely Associated with the Severity of Liver Damage in Genotype 1 Chronic Hepatitis C Patients. |
Articolo in rivista |
Vai |
| 2015 |
Statin use and non-alcoholic steatohepatitis in at risk individuals |
Articolo in rivista |
Vai |
| 2015 |
Response to Dr. Sertoglu and colleagues |
Lettera |
Vai |
| 2015 |
The UCP2 -866 G>A promoter region polymorphism is associated with nonalcoholic steatohepatitis |
Articolo in rivista |
Vai |
| 2014 |
Glucokinase Regulatory Protein Gene Polymorphism Affects Liver Fibrosis in Non-Alcoholic Fatty Liver Disease |
Articolo in rivista |
Vai |
| 2014 |
Cost-effectiveness of sofosbuvir-based triple therapy for untreated patients with genotype 1 chronic hepatitis C |
Articolo in rivista |
Vai |
| 2014 |
EFFICACY AND SAFETY OF BOCEPREVIR-BASED THERAPY IN
HCVG1 TREATMENT-EXPERIENCED PATIENTS WITH ADVANCED
FIBROSIS/CIRRHOSIS: THE ITALIAN AND SPANISH NPP EARLY
ACCESS PROGRAM |
Proceedings (TIPOLOGIA NON ATTIVA) |
Vai |
| 2014 |
Identification of naïve HCV-1 patients with chronic hepatitis who may benefit from dual therapy with peg-interferon and ribavirin |
Articolo in rivista |
Vai |
| 2014 |
Real-world outcomes in patients with chronic hepatitis C: primary results of the PROBE study. |
Articolo in rivista |
Vai |
| 2014 |
health policy model: long-term predictive results associated with the management of hepatitis C virus-induced diseases in italy |
Articolo in rivista |
Vai |
| 2014 |
Reply to: Is industrial fructose just a marker of an unhealthy dietary pattern? |
Recensione in rivista |
Vai |
| 2014 |
Clinical implications of the hyperdynamic syndrome in cirrhosis. |
Articolo in rivista |
Vai |
| 2014 |
Considerations regarding the alleged association between Herbalife products and cases of hepatotoxicity: a rebuttal |
Articolo in rivista |
Vai |
| 2014 |
Simeprevir with pegylated interferon alfa 2a plus ribavirin in treatment-naive patients with chronic hepatitis C virus genotype 1 infection (QUEST-1): a phase 3, randomised, double-blind, placebo-controlled trial |
Articolo in rivista |
Vai |
| 2014 |
Performance of two HCV RNA assays during protease inhibitor-based triple therapy in patients with advanced liver fibrosis and cirrhosis. |
Articolo in rivista |
Vai |
| 2014 |
An a priori prediction model of response to peginterferon plus ribavirin dual therapy in naïve patients with genotype 1 chronic hepatitis C |
Articolo in rivista |
Vai |
| 2014 |
The risk of hepatocellular carcinoma in HBV cirrhosis is affected by polymorphisms of the MERTK gene |
Abstract in rivista |
Vai |
| 2014 |
Regression of fibrosis after HBV antiviral therapy. Is cirrhosis reversible? |
Articolo in rivista |
Vai |
| 2014 |
Steatosis affects the performance of liver stiffness measurement for fibrosis assessment in patients with genotype 1 chronic hepatitis C |
Articolo in rivista |
Vai |
| 2014 |
HCV cirrhosis at the edge of decompensation: Will ABT-450/r, ombitasvir, da- sabuvir and ribavirin solve the need for treatment? |
Recensione in rivista |
Vai |
| 2014 |
Clinical features and outcomes of patients with drug-induced autoimmune hepatitis: A retrospective cohort study. |
Articolo in rivista |
Vai |
| 2014 |
EASL Clinical Practice Guidelines: management of hepatitis C virus infection |
Articolo in rivista |
Vai |
| 2014 |
CT enterography as a powerful tool for the evaluation of inflammatory activity in Crohn's disease: relationship of CT findings with CDAI and acute-phase reactants |
Articolo in rivista |
Vai |
| 2014 |
HCV-1b intra-subtype variability: Impact on genetic barrier to protease inhibitors |
Articolo in rivista |
Vai |
| 2014 |
Liver function test abnormalities in patients with inflammatory bowel diseases: A hospital-based survey |
Articolo in rivista |
Vai |
| 2014 |
Personalized cost-effectiveness of boceprevir-based triple therapy for untreated patients with genotype 1 chronic hepatitis C |
Articolo in rivista |
Vai |
| 2014 |
The dilemma for patients with chronic hepatitis C: treat now or warehouse? |
Recensione in rivista |
Vai |
| 2014 |
Reply to: “Industrial, not fruit fructose intake is associated with the severity of liver fibrosis in genotype 1 chronic hepatitis C patients” |
Recensione in rivista |
Vai |
| 2013 |
NT pro BNP plasma level and atrial volume are linked to the severity of liver cirrhosis. |
Articolo in rivista |
Vai |
| 2013 |
Survival of Patients with Hepatocellular Carcinoma (HCC)
Treated by Percutaneous Radio-Frequency Ablation
(RFA) Is Affected by Complete Radiological Response |
Abstract in rivista |
Vai |
| 2013 |
Immunological alterations in hepatitis C virus infection |
Articolo in rivista |
Vai |
| 2013 |
Clinical course and prognostic factors of hepatorenal syndrome: A retrospective single-center cohort study |
Articolo in rivista |
Vai |
| 2013 |
Reply to: "IL28B rs12979860 is not associated with histologic features of NAFLD in a cohort of Caucasian North American patients". |
Articolo in rivista |
Vai |
| 2013 |
Is the efficacy of sorafenib treatment in patients with hepatocellular carcinoma affected by age? |
Articolo in rivista |
Vai |
| 2013 |
Modified spleen stiffness measurement by transient elastography is associated with presence of large oesophageal
varices in patients with compensated hepatitis C virus cirrhosis |
Articolo in rivista |
Vai |
| 2013 |
High sCD36 plasma level is associated with steatosis and its severity in patients with genotype 1 chronic hepatitis C |
Articolo in rivista |
Vai |
| 2013 |
Association of vitamin D serum levels and its common genetic determinants with severity of liver fibrosis in genotype 1 chronic hepatitis C patients |
Proceedings (TIPOLOGIA NON ATTIVA) |
Vai |
| 2013 |
Reply. |
Articolo in rivista |
Vai |
| 2013 |
Body Mass Index and Liver Stiffness Affect Accuracy of Ultrasonography in Detecting Steatosis in Patients With Chronic Hepatitis C Virus Genotype 1 Infection |
Articolo in rivista |
Vai |
| 2013 |
Role of IL-28B and inosine triphosphatase polymorphisms in efficacy and safety of Peg-Interferon and ribavirin in chronic hepatitis C compensated cirrhosis with and without oesophageal varices. |
Articolo in rivista |
Vai |
| 2013 |
A rs4374383 Single Nucleotide Polymorphisms of MERTK gene is linked to a higher likelihood of hepatocellular carcinoma in patients with HCV cirrhosis |
Abstract in rivista |
Vai |
| 2013 |
Effects of IL28B rs12979860 CC genotype on metabolic profile and sustained virologic response in patients with genotype 1 chronic hepatitis C |
Articolo in rivista |
Vai |
| 2013 |
HBsAg quantification in HBeAg negative cirrhosis on nucleoside/nucleotide analogue (NA) and risk of development of HCC |
Abstract in rivista |
Vai |
| 2013 |
Association of vitamin D serum levels and its common genetic determinants, with severity of liver fibrosis in genotype 1 chronic hepatitis C patients |
Articolo in rivista |
Vai |
| 2013 |
Predicting Early and Sustained Virological Responses in Prior Nonresponders to Pegylated Interferon alpha-2b Plus Ribavirin Retreated With Peginterferon alpha-2a Plus Ribavirin and The Benefit-Risk Ratio of Retreatment t |
Articolo in rivista |
Vai |
| 2013 |
HCV genotype 5: an orphan virus |
Articolo in rivista |
Vai |
| 2013 |
Cardiovascular diseases and HCV infection: a simple association or more? |
Articolo in rivista |
Vai |
| 2013 |
Anemia during treatment with peginterferon Alfa-2b/ribavirin and boceprevir: Analysis from the serine protease inhibitor therapy 2 (SPRINT-2) trial. |
Articolo in rivista |
Vai |
| 2013 |
In vivo liver expression of TLR2, TLR3 and TLR7 in chronic hepatitis C |
Articolo in rivista |
Vai |
| 2013 |
Who is more likely to respond to dual treatment with pegylated-interferon and ribavirin for chronic hepatitis C? A gender-oriented analysis. |
Articolo in rivista |
Vai |
| 2013 |
Herbal hepatotoxicity: a hidden epidemic |
Articolo in rivista |
Vai |
| 2013 |
Management of infections pre- and post-liver transplantation: Report of an AISF consensus conference |
Articolo in rivista |
Vai |
| 2013 |
Osteodystrophy in chronic liver diseases |
Articolo in rivista |
Vai |
| 2013 |
Cost-effectiveness of sorafenib treatment in field practice for patients with hepatocellular carcinoma. |
Articolo in rivista |
Vai |
| 2013 |
Non invasive indexes for the assessment of patients with non-alcoholic fatty liver disease |
Articolo in rivista |
Vai |
| 2013 |
Industrial, not fruit fructose intake is associated with the severity of liver fibrosis in genotype 1 chronic hepatitis C patients |
Articolo in rivista |
Vai |
| 2013 |
How to optimize HCV therapy in genotype 1 patients: predictors of response. |
Articolo in rivista |
Vai |
| 2013 |
Viral Sequence Analysis of Occult HBV Infection and Its Reactivation in Immunosuppressed Patients |
Articolo in rivista |
Vai |
| 2013 |
PNPLA3 GG Genotype and Carotid Atherosclerosis in Patients with Non-Alcoholic Fatty Liver Disease |
Articolo in rivista |
Vai |
| 2013 |
No detection of occult HBV-DNA in patients with various rheumatic diseases treated with anti-TNF agents: a two-year prospective study. |
Articolo in rivista |
Vai |
| 2013 |
Cost-effectiveness of boceprevir or telaprevir for previously treated patients with genotype 1 chronic hepatitis C |
Articolo in rivista |
Vai |
| 2012 |
Natural history of untreatable hepatocellular carcinoma: A retrospective cohort study |
Articolo in rivista |
Vai |
| 2012 |
Chronic hepatitis C and atherosclerosis: A complex pathogenic puzzle. |
Articolo in rivista |
Vai |
| 2012 |
Phylogenetic Analysis of isolates from new cases of HBV infection in Southern Italy. |
Articolo in rivista |
Vai |
| 2012 |
herapeutic algorithms for chronic hepatitis C in the DAA era during the current economic crisis: whom to treat? How to treat? When to
treat? |
Articolo in rivista |
Vai |
| 2012 |
Liver follicular helper T-cells predict the achievement of virological response following interferon-based treatment in HCV-infected patients. |
Articolo in rivista |
Vai |
| 2012 |
Randomized trial of albinterferon alfa-2b every 4 weeks for
chronic hepatitis C virus genotype 2/3 |
Articolo in rivista |
Vai |
| 2012 |
Clinical management of drug-drug interactions in HCV therapy: Challenges and solutions. |
Articolo in rivista |
Vai |
| 2012 |
Cost-Effectiveness of Boceprevir or Telaprevir for Untreated Patients with
Genotype 1 Chronic Hepatitis C |
Articolo in rivista |
Vai |
| 2012 |
IL28B polymorphisms influence stage of fibrosis and
spontaneous or interferon-induced viral clearance in thalassemia patients with
hepatitis C virus infection. |
Articolo in rivista |
Vai |
| 2012 |
Peginterferon alfa-2b plus weight-based ribavirin for 24 weeks in patients
with chronic hepatitis C virus genotype 1 with low viral load who achieve rapid
viral response |
Articolo in rivista |
Vai |
| 2012 |
Hyperuricaemia:
another metabolic feature affecting the severity of chronic hepatitis because of
HCV infection. |
Articolo in rivista |
Vai |
| 2012 |
Visceral adiposity index is associated with significant fibrosis in patients with non-alcoholic fatty liver disease |
Articolo in rivista |
Vai |
| 2012 |
Plasma biomarkers as predictors of outcome in patients
with advanced hepatocellular carcinoma |
Articolo in rivista |
Vai |
| 2012 |
Personality Traits, Defense Mechanisms and Perception of Quality of Life (QOL) in Patients With Inflammatory Bowel Disease (IBD) and Matched Controls |
Proceedings (TIPOLOGIA NON ATTIVA) |
Vai |
| 2012 |
Factors that predict response of patients with hepatitis C virus infection to boceprevir |
Articolo in rivista |
Vai |
| 2012 |
Fluoroquinolone-induced liver injury: three new cases and a review of the literature. |
Articolo in rivista |
Vai |
| 2012 |
Risk of disease decompensation and HCC in patients with HCV cirrhosis non responders to PEG IFN plus RBV |
Abstract in rivista |
Vai |
| 2012 |
Preface. Hepatitis C infection. |
Recensione in rivista |
Vai |
| 2012 |
Inverse correlation between plasma oxysterol and LDL-cholesterol levels in hepatitis C virus-infected patients. |
Articolo in rivista |
Vai |
| 2012 |
Optimized threshold for serum HCV RNA to predict treatment outcomes in hepatitis C patients receiving peginterferon alfa-2a/ribavirin |
Articolo in rivista |
Vai |
| 2012 |
Assessment by Fibroscan of fibrosis in nonalcoholic fatty
liver disease: XL versus M probe? |
Articolo in rivista |
Vai |
| 2012 |
Vitamin D levels and IL28B polymorphisms are related to rapid virological response to standard of care in genotype 1 chronic hepatitis C. |
Articolo in rivista |
Vai |
| 2012 |
Fecal calprotectin in clinical practice: a noninvasive screening tool for patients with chronic diarrhea |
Articolo in rivista |
Vai |
| 2012 |
IL28B and PNPLA3 Polymorphisms Affect Histological Liver Damage in Patients with Non-alcoholic Fatty Liver Disease. |
Articolo in rivista |
Vai |
| 2012 |
"Should cirrhosis change our attitude towards treating non-hepatic cancer?" |
Articolo in rivista |
Vai |
| 2012 |
Serology in adults with celiac disease: limited accuracy in patients with mild histological lesions. |
Articolo in rivista |
Vai |
| 2012 |
Eltrombopag before procedures in patients with cirrhosis and thrombocytopenia |
Articolo in rivista |
Vai |
| 2012 |
Hepatitis C in the elderly: a multicentre
cross-sectional study by the Italian Association for the Study of the Liver |
Articolo in rivista |
Vai |
| 2012 |
Methylenetetrahydrofolate reductase homozygosis
and low-density lipoproteins in patients with genotype 1 chronic hepatitis C |
Articolo in rivista |
Vai |
| 2012 |
Serum γ-glutamyl transferase levels, insulin resistance and liver fibrosis in
patients with chronic liver diseases. |
Articolo in rivista |
Vai |
| 2012 |
Efficacy and safety of sorafenib in
patients with advanced hepatocellular carcinoma: subanalyses of a phase III
trial |
Articolo in rivista |
Vai |
| 2011 |
High liver RBP4 protein content is associated with histological features in patients with genotype 1 chronic hepatitis C and with nonalcoholic steatohepatitis |
Articolo in rivista |
Vai |
| 2011 |
Reliability of liver stiffness measurement in non-alcoholic fatty liver disease: the effects of body mass index. |
Articolo in rivista |
Vai |
| 2011 |
Occult hepatitis B virus
infection and hepatocellular carcinoma development in patients with chronic
hepatitis C |
Recensione in rivista |
Vai |
| 2011 |
Carotid atherosclerosis and chronic hepatitis C: A prospective study of risk associations. |
Articolo in rivista |
Vai |
| 2011 |
Optimal therapy in hepatitis C virus genotypes 2 and 3 patients. |
Articolo in rivista |
Vai |
| 2011 |
Fibrosis in chronic viral hepatitis |
Articolo in rivista |
Vai |
| 2011 |
Genetic predisposition to thrombophilia in inflammatory bowel disease |
Articolo in rivista |
Vai |
| 2011 |
Is liver stiffness measurement unreliable in obese patients? authors' reply. |
Articolo in rivista |
Vai |
| 2011 |
LIVER RELATED EVENTS AND SURVIVAL IN PATIENTS WITH COMPENSATED HCV CIRRHOSIS: THE ROLE OF SUSTAINED VIROLOGICAL RESPONSE TO PEG-IFN BASED THERAPY AND PORTAL HYPERTENSION |
Abstract in rivista |
Vai |
| 2011 |
Liver follicular helper T-cells in chronic hepatitis C |
Abstract in rivista |
Vai |
| 2011 |
PEG-INTERFERON PLUS RIBAVIRIN IN HCV CIRRHOSIS WITH PORTAL HYPERTENSION: ROLE OF VIRAL AND HOST FACTORS IN HCV CLEARANCE |
Abstract in rivista |
Vai |
| 2011 |
Field-practice study of sorafenib therapy for hepatocellular carcinoma: a prospective multicenter study in Italy. |
Articolo in rivista |
Vai |
| 2011 |
Hyperuricemia is associated with histological liver damage in patients with non-alcoholic fatty liver disease. |
Articolo in rivista |
Vai |
| 2011 |
LIPIDOMICS OF FATTY LIVER IN NAFLD AND HCV INFECTION: LIVER SPHYNGOLIPIDS AND FATTY
ACIDS |
Proceedings (TIPOLOGIA NON ATTIVA) |
Vai |
| 2011 |
FOLLICULAR HELPER T-CELLS POPULATE THE INTRAHEPATIC INFILTRATES OF HCV GENOTYPE-1 CHRONICALLY INFECTED PATIENTS AND PREDICT THE ACHIEVEMENT OF VIROLOGICAL RESPONSE FOLLOWING IFN-BASED TREATMENT |
Abstract in rivista |
Vai |
| 2011 |
LOW VITAMIN D SERUM LEVEL IS RELATED TO RAPID, EARLY AND SUSTAINED VIROLOGICAL RESPONSE TO IFN-BASED THERAPY IN GENOTYPE 1 CHRONIC HEPATITIS C |
Abstract in rivista |
Vai |
| 2011 |
Hepatic steatosis and insulin resistance are associated with severe fibrosis in patients with chronic hepatitis caused by HBV or HCV infection. |
Articolo in rivista |
Vai |
| 2011 |
Liver stiffness measurement by transient elastography predicts early recovery from acute hepatitis |
Recensione in rivista |
Vai |
| 2011 |
Management of hepatitis B virus infection in the underprivileged world. |
Articolo in rivista |
Vai |
| 2011 |
Oesophagogastroduodenoscopy
in patients with cirrhosis: Extending the range of detection beyond portal
hypertension |
Articolo in rivista |
Vai |
| 2011 |
Treatment of chronic
hepatitis B: update of the recommendations from the 2007 Italian Workshop |
Articolo in rivista |
Vai |
| 2011 |
TyG index, HOMA score and viral load in patients with chronic hepatitis C due to genotype 1. |
Articolo in rivista |
Vai |
| 2011 |
FibroTest is an independent predictor of virologic response in
chronic hepatitis C patients retreated with pegylated interferon alfa-2b and
ribavirin in the EPIC³ program |
Articolo in rivista |
Vai |
| 2011 |
Hyperuricemia in non-alcoholic fatty liver disease: authors' reply. |
Articolo in rivista |
Vai |
| 2011 |
European Association for the Study of the Liver. EASL Clinical Practice
Guidelines: management of hepatitis C virus infection |
Articolo in rivista |
Vai |
| 2011 |
Comparison of transient elastography and acoustic radiation force impulse for non-invasive staging of liver fibrosis in patients with chronic hepatitis C. |
Articolo in rivista |
Vai |
| 2011 |
Predicting survival in patients with hepatocellular carcinoma
treated by transarterial chemoembolisation |
Articolo in rivista |
Vai |
| 2010 |
Epidemiology, risk factors and surveillance of hepatocellular carcinoma |
Articolo in rivista |
Vai |
| 2010 |
Liver stiffness, a non-invasive
marker of liver disease: a core study group report |
Articolo in rivista |
Vai |
| 2010 |
INSULIN RESISTANCE, STEATOSIS AND PROGRESSION OF FIBROSIS IN PATIENTS WITH GENOTYPE 1 CHRONIC
HEPATITIS C |
Proceedings (TIPOLOGIA NON ATTIVA) |
Vai |
| 2010 |
Reply |
Articolo in rivista |
Vai |
| 2010 |
Hepatocellular carcinoma and non-alcoholic fatty liver disease: from a clinical to a molecular association. |
Articolo in rivista |
Vai |
| 2010 |
Clinical course and outcomes of drug-induced liver injury: Nimesulide as the first implicated medication. |
Articolo in rivista |
Vai |
| 2010 |
PHYLOGENETIC ANALYSIS OF HBV INFECTION IN SICILY: IS THE EPIDEMIOLOGY CHANGING? |
Abstract in rivista |
Vai |
| 2010 |
Intrahepatic IgG/IgM plasma cells ratio helps in classifying autoimmune liver diseases. |
Articolo in rivista |
Vai |
| 2010 |
Visceral adiposity index is associated with histological findings and high viral load in patients with chronic hepatitis C due to genotype 1. |
Articolo in rivista |
Vai |
| 2010 |
Does chemotherapy prevent HCV-related hepatocellular carcinoma? Cons |
Articolo in rivista |
Vai |
| 2010 |
Replay |
Articolo in rivista |
Vai |
| 2010 |
LOW VITAMIN D SERUM LEVEL IS RELATED TO RAPID, EARLY AND SUSTAINED VIROLOGICAL RESPONSE TO IFN-BASED THERAPY IN GENOTYPE 1 CHRONIC HEPATITIS C |
Abstract in rivista |
Vai |
| 2010 |
Halitosis: could it be more than mere bad breath? |
Articolo in rivista |
Vai |
| 2010 |
Low vitamin D serum level is related to severe fibrosis and low responsiveness to interferon-based therapy in genotype 1 chronic hepatitis C |
Articolo in rivista |
Vai |
| 2010 |
Expansion of intestinal CD4+CD25(high) Treg
cells in patients with ankylosing spondylitis: a putative role for interleukin-10 in preventing intestinal Th17 response |
Articolo in rivista |
Vai |
| 2010 |
Efficacy of boceprevir, an NS3 protease inhibitor, in combination with
peginterferon alfa-2b and ribavirin in treatment-naive patients with genotype 1
hepatitis C infection (SPRINT-1): an open-label, randomised, multicentre phase 2
trial |
Articolo in rivista |
Vai |
| 2010 |
A meta-analysis of survival rates of untreated patients in randomized clinical trials of hepatocellular carcinoma. |
Articolo in rivista |
Vai |
| 2010 |
HEPATIC STEATOSIS IS ASSOCIATED WITH SEVERE FIBROSIS IN PATIENTS WITH CHRONIC HEPATITIS B |
Proceedings (TIPOLOGIA NON ATTIVA) |
Vai |
| 2010 |
FOLLICULAR HELPER T-CELLS POPULATE THE INTRAHEPATIC INFILTRATES OF HCV GENOTYPE-1 CHRONICALLY INFECTED PATIENTS AND PREDICT THE ACHIEVEMENT OF VIROLOGICAL RESPONSE FOLLOWING IFN-BASED TREATMENT |
Abstract in rivista |
Vai |
| 2010 |
PEG IFN alfa-2a vs. alfa-2b: And the winner is ...? |
Articolo in rivista |
Vai |
| 2010 |
Practice guidelines for the treatment of hepatitis C: recommendations from an AISF/SIMIT/SIMAST Expert Opinion Meeting. |
Articolo in rivista |
Vai |
| 2009 |
Oral dysphagia. An unique symptom for a wide spectrum of diseases |
Articolo in rivista |
Vai |
| 2009 |
Reply |
Articolo in rivista |
Vai |
| 2009 |
Variability of reverse transcriptase and overlapping S gene in hepatitis B virus isolates from untreated and lamivudine-resistant chronic hepatitis B patients. |
Articolo in rivista |
Vai |
| 2009 |
Histomorphology of healthy oral mucosa in untreated celiac patients: unexpected association with spongiosis. |
Articolo in rivista |
Vai |
| 2009 |
Chronic hepatitis B: who to treat and which choice of treatment? |
Articolo in rivista |
Vai |
| 2009 |
Clinical trial: High-dose furosemide plus small-volume hypertonic saline solutions vs. repeated paracentesis as treatment of refractory ascites. |
Articolo in rivista |
Vai |
| 2009 |
Hepatocellular Cancer: Optimal
Strategies for Screening and Surveillance |
Articolo in rivista |
Vai |
| 2009 |
Time course of insulin resistance during antiviral
therapy in non-diabetic, non-cirrhotic patients with
genotype 1 HCV infection |
Articolo in rivista |
Vai |
| 2009 |
PEG-interferon plus Ribavirin in compensated HCV cirrhosis with portal hypertension: the role of rapid and early virological response in predicting the sustained virological response |
Proceedings (TIPOLOGIA NON ATTIVA) |
Vai |
| 2009 |
The neglected hepatitis C virus genotypes 4, 5 and 6: an international consensus
report |
Articolo in rivista |
Vai |
| 2009 |
Fibrosis staging in chronic hepatitis C: analysis of discordance between transient elastography and liver biopsy |
Articolo in rivista |
Vai |
| 2009 |
Retreatment with pegylated interferon plus ribavirin of chronic
hepatitis C non-responders to interferon plus ribavirin: A meta-analysis. |
Articolo in rivista |
Vai |
| 2009 |
Re-treatment of Patients With Chronic Hepatitis C Who Do Not Respond to Peginterferon-[alpha]2b: A Randomized Trial |
Articolo in rivista |
Vai |
| 2009 |
Hyperferritinemia is a risk factor
for steatosis in chronic liver disease. |
Articolo in rivista |
Vai |
| 2009 |
Metastatic hepatocellular carcinoma of the parotid region without lung metastasis:a case report |
Articolo in rivista |
Vai |
| 2009 |
Small intestine bacterial overgrowth and irritable bowel syndrome-related symptoms: experience with Rifaximin. |
Articolo in rivista |
Vai |
| 2009 |
OptimizingthetreatmentofchronichepatitisduetohepatitisCvirus
genotypes 2 and 3: a review |
Articolo in rivista |
Vai |
| 2009 |
Implication of Normal Liver Enzymes in Liver Disease |
Articolo in rivista |
Vai |
| 2009 |
Reducing treatment duration in patients infected with hepatitis C
genotype 1: any need for further studies? |
Articolo in rivista |
Vai |
| 2009 |
Non-alcoholic fatty liver disease pathogenesis: The present and the future |
Articolo in rivista |
Vai |
| 2009 |
Insulin resistance is a risk factor for esophageal varices in hepatitis C virus
cirrhosis. |
Articolo in rivista |
Vai |
| 2009 |
Insulin resistance is a major determinant of liver stiffness in nondiabetic patients with HCV genotype 1 chronic hepatitis |
Articolo in rivista |
Vai |
| 2009 |
Noninvasive assessment of liver fibrosis in thalassaemia major patients by transient elastography (TE) - lack of interference by iron deposition. |
Articolo in rivista |
Vai |
| 2009 |
Multimodal approaches to the treatment of hepatocellular carcinoma. |
Articolo in rivista |
Vai |
| 2009 |
HCV genotypes in Sicily: is there any evidence of a shift? |
Articolo in rivista |
Vai |
| 2009 |
EVALUATING THE RISK OF HEPATITIS B REACTIVATION IN PATIENTS WITH HAEMATOLOGICAL MALIGNANCIES: IS THE SERUM HEPATITIS B PROFILE RELIABLE? |
Articolo in rivista |
Vai |
| 2009 |
Peginterferon alfa-2b and Ribavirin: Effective in Patients With Hepatitis C
Who Failed Interferon alfa/Ribavirin Therapy |
Articolo in rivista |
Vai |
| 2009 |
Overexpression of interleukin-23, but not interleukin-17, as an immunologic signature of subclinical intestinal inflammation in ankylosing spondylitis |
Articolo in rivista |
Vai |
| 2009 |
PEG_interferon plus Ribavirin in compensated HCV cirrhosis with portal hypertension: the role of rapid and early virological response in predicting the sustained virological response |
Proceedings (TIPOLOGIA NON ATTIVA) |
Vai |
| 2009 |
Reply |
Articolo in rivista |
Vai |
| 2009 |
HEPATITIS C AND DIABETES: THE INEVITABLE COINCIDENCE? |
Articolo in rivista |
Vai |
| 2009 |
PEG-INTERFERON PLUS RIBAVIRIN IN COMPENSATED HCV CIRRHOSIS WITH PORTAL HYPERTENSION: THE ROLE OF RAPID AND EARLY VIROLOGICAL RESPONSE IN PREDICTING THE SUSTAINED VIROLOGICAL RESPONSE |
Abstract in rivista |
Vai |
| 2009 |
Serum BLyS/BAFF predicts the outcome of acute hepatitis C virus infection |
Articolo in rivista |
Vai |
| 2009 |
HCV CLEARANCE AFTER PEG IFN PLUS RBV IMPROVES THE COURSE OF HCV CIRRHOSIS REGARDLESS OF PORTAL HYPERTENSION |
Abstract in rivista |
Vai |
| 2008 |
Retinol-binding protein 4 (RBP4) : a new marker of G1 HCV-induced steatosis |
Articolo in rivista |
Vai |
| 2008 |
Survival of patients with hepatocellular carcinoma in cirrhosis: a comparison of BCLC, CLIP and GRETCH staging systems |
Articolo in rivista |
Vai |
| 2008 |
Extrahepatic manifestations of hepatitis C virus infection. |
Articolo in rivista |
Vai |
| 2008 |
751 RETINOL-BINDING PROTEIN 4 (RBP4): A NEW MARKER OF G1 HCV-INDUCED STEATOSIS |
Articolo in rivista |
Vai |
| 2008 |
Insulin resistance and diabetes increase fibrosis in the liver of patients with
genotype 1 HCV infection. |
Articolo in rivista |
Vai |
| 2008 |
Coeliac disease: Oral ulcer prevalence, assessment of risk and association with gluten-free diet in children. |
Articolo in rivista |
Vai |
| 2008 |
Inguinal hernioplasty improves the quality of life in patients with cirrhosis. |
Articolo in rivista |
Vai |
| 2008 |
Retinol-binding protein 4: a new marker of virus-induced steatosis in patients infected with hepatitis C virus genotype 1. |
Articolo in rivista |
Vai |
| 2008 |
CLINICAL COURSE OF NIMESULIDE-INDUCED LIVER INJURY |
Proceedings (TIPOLOGIA NON ATTIVA) |
Vai |
| 2008 |
Introduction. Necroinflammation and the course of chronic hepatitis. |
Articolo in rivista |
Vai |
| 2008 |
HCV genotypes in western Sicily: any evidence for a shift? |
Proceedings (TIPOLOGIA NON ATTIVA) |
Vai |
| 2008 |
Liver disease in chelated transfusion-dependent thalassemics: the role of iron and chronic hepatitis C |
Articolo in rivista |
Vai |
| 2008 |
Phylogenetic Reconstruction of HCV Genotype 1b Dissemination in a Small City Centre: The
Camporeale Model |
Articolo in rivista |
Vai |
| 2008 |
Statements from the Taormina expert meeting on occult hepatitis B virus infection. |
Articolo in rivista |
Vai |
| 2008 |
Serum BLYS/BAFF levels in acute hepatitis C predict clinical outcome |
Proceedings (TIPOLOGIA NON ATTIVA) |
Vai |
| 2008 |
Hepatitis C virus (HCV) infection: a systemic disease. |
Articolo in rivista |
Vai |
| 2008 |
Liver disease in chelated transfusion-dependent thalassemics: the role of iron overload and chronic hepatitis C. |
Articolo in rivista |
Vai |
| 2008 |
Assessment of hepatitis C virus-RNA clearance under combination therapy for hepatitis C virus genotype 1: performance of transcription-mediated amplification assay |
Articolo in rivista |
Vai |
| 2008 |
Seeding after radiofrequency ablation of hepatocellular carcinoma in patients with cirrhosis: a prospective study. |
Articolo in rivista |
Vai |
| 2008 |
Liver eosinophilic infiltrate is a significant finding in patients with chronic hepatitis C. |
Articolo in rivista |
Vai |
| 2008 |
Reply |
Articolo in rivista |
Vai |
| 2007 |
Virus-related insulin resistance in HCV genotype 1 chronic hepatitis C : a major disease modifier |
Proceedings (TIPOLOGIA NON ATTIVA) |
Vai |
| 2007 |
Seeding after radiofrequency thermal ablation of hepatocellular carcinoma in cirrhosis: a prospective study |
Proceedings (TIPOLOGIA NON ATTIVA) |
Vai |
| 2007 |
Oral Mucosa of celiac disease patients produces anti-endomysial and anti-transglutaminase antibodes. Diagnostic usefulness of an in vitro culture system |
Articolo in rivista |
Vai |
| 2007 |
Mortality in patients with hepatocellular carcinoma predicted by six scoring: none is the winner |
Proceedings (TIPOLOGIA NON ATTIVA) |
Vai |
| 2007 |
The impact of sustained virological response on clinical outcomes in compensated HCV cirrhosis: a prospective cohort study |
Proceedings (TIPOLOGIA NON ATTIVA) |
Vai |
| 2007 |
STAGING OF FIBROSIS BY LIVER STIFFNESS MEASUREMENT IN THALASSEMICS WITH IRON OVERLOAD |
Proceedings (TIPOLOGIA NON ATTIVA) |
Vai |
| 2007 |
Which patients with genotype 1 chronic hepatitis C can benefit from prolonged
treatment with the 'accordion' regimen? |
Articolo in rivista |
Vai |
| 2007 |
Peg-interferon alone or combined with ribavirin in HCV cirrhosis with portal hypertension:a randomized controlled trial |
Articolo in rivista |
Vai |
| 2007 |
The impact of insulin resistance, serum adipocytokines and visceral obesity on steatosis and fibrosis in patients with chronic hepatitis C. |
Articolo in rivista |
Vai |
| 2007 |
Adefovir for lamivudine resistant HBV: More than meets the eye. |
Articolo in rivista |
Vai |
| 2007 |
Oral pathology in untreated coeliac disease |
Articolo in rivista |
Vai |
| 2007 |
INSULIN RESISTANCE AND SEVERITY OF
FIBROSIS IN HCV GENOTYPE 1 CHRONIC HEPATITIS. |
Proceedings (TIPOLOGIA NON ATTIVA) |
Vai |
| 2006 |
From viral pathobiology to the treatment of hepatitis B virus infection EASL Monothematic Conference (Istanbul, Turkey, October 6-8, 2005). |
Articolo in rivista |
Vai |
| 2006 |
Halitosis and HCV-related liver disease:true association |
Proceedings (TIPOLOGIA NON ATTIVA) |
Vai |
| 2006 |
Modulation of epitope-specific anti-hepatitis C virus E2(anti-HCV/E2)antibodies by anti-viral treatment |
Articolo in rivista |
Vai |
| 2006 |
Treating patients with HCV genotype 1 and low viraemia: more than meets the eye |
Articolo in rivista |
Vai |
| 2006 |
Histomorphological features of healthy oral mucosa in coeliac patients: unexpected association with spongiosis”. |
Proceedings (TIPOLOGIA NON ATTIVA) |
Vai |
| 2006 |
Characteristics of HCV positive subjects referring to hospitals in Italy: a multicentre prevalence study on 6,999 cases |
Articolo in rivista |
Vai |
| 2006 |
Different doses of consensus interferon plus ribavirin in patients with hepatitis C virus genotype 1 relapsed after interferon monotherapy: a randomized controlled trial |
Articolo in rivista |
Vai |
| 2006 |
Histomorphological features of health oral mucosa in celiac patients:unexspected association with spongiosis. |
Proceedings (TIPOLOGIA NON ATTIVA) |
Vai |
| 2006 |
Treatment options in HBV. |
Articolo in rivista |
Vai |
| 2006 |
Chemoprevention of hepatocellular carcinoma. |
Capitolo o Saggio |
Vai |
| 2006 |
Epatite cronica C: l'ottimizzazione della terapia. |
Monografia |
Vai |
| 2006 |
GRAVE EMORRAGIA RICORRENTE DEL CONDOTTO ILEALE DA IPERTENSIONE PORTALE: PRIMA ESPERIENZA MONDIALE CON SCLEROTIZZAZIONE VASALE ECOGUIDATA |
Articolo in rivista |
Vai |
| 2006 |
Acute hepatitis C: in search of the optimal approach to cure. |
Articolo in rivista |
Vai |
| 2006 |
Reversibility of fibrosis |
Capitolo o Saggio |
Vai |
| 2006 |
Insulin resistance is associated with steatosis in non-diabetic patients with genotype 1 chronic hepatitis C |
Articolo in rivista |
Vai |
| 2006 |
Oxidative stress inhibits IFN-alpha-induced antiviral gene expression by blocking the JAK-STAT pathway. |
Articolo in rivista |
Vai |
| 2005 |
Epidemiologia molecolare dell'infezione da HCV in un Comune Siciliano |
Proceedings (TIPOLOGIA NON ATTIVA) |
Vai |
| 2005 |
Treatment of hepatocellular carcinoma in compensated cirrhosis with radio-frequency thermal ablation (RFTA): a prospective study |
Articolo in rivista |
Vai |
| 2005 |
Infezione occulta da HBV in pazienti con malattie oncoematologiche |
Proceedings (TIPOLOGIA NON ATTIVA) |
Vai |
| 2005 |
GRAVE EMORRAGIA RICORRENTE DEL CONDOTTO ILEALE DA IPERTENSIONE PORTALE: PRIMA ESPERIENZA MONDIALE CON SCLEROTIZZAZIONE VASALE ECOGUIDATA. |
Proceedings (TIPOLOGIA NON ATTIVA) |
Vai |
| 2005 |
Radio-frequency thermal ablation (RFTA) of small hepatocellular carcinoma in patients with cirrhosis. Experience at a single tertiary referral center |
Articolo in rivista |
Vai |
| 2005 |
GRAVE EMORRAGIA RICORRENTE DEL CONDOTTO ILEALE DA IPERTENSIONE PORTALE . PRIMA ESPERIENZA MONDIALE CON SCLEROTIZZAZIONE ECOGUIDATA |
Capitolo o Saggio |
Vai |
| 2005 |
Hepatitis B virus reactivation and
alemtuzumab therapy |
Articolo in rivista |
Vai |
| 2005 |
La malattia epatica da epatite C: una condizione guaribile? |
Articolo in rivista |
Vai |
| 2005 |
Predicting sustained virological responses in chronic hepatitis C patients treated with peginterferon alfa-2a (40 KD)/ribavirin |
Articolo in rivista |
Vai |
| 2005 |
Prevention of hepatocellular carcinoma |
Articolo in rivista |
Vai |
| 2005 |
Valutazione della clearance di HCV-RNA sotto trattamentio antivirale con Transcription-Mediated Amplification (TMA) |
Proceedings (TIPOLOGIA NON ATTIVA) |
Vai |
| 2005 |
Validity and reliability of the Italian version of the Chronic Liver Disease Questionnaire (CLDQ-I) for the assessment of health-related quality of life |
Articolo in rivista |
Vai |
| 2005 |
Response to letter from Professor Peter Ferenci |
Articolo in rivista |
Vai |
| 2005 |
HBV-DNA suppression and disease course in HBV cirrhosis patients on long-term lamivudine therapy |
Articolo in rivista |
Vai |
| 2005 |
Cinetica della risposta virologica e della comparsa di mutanti virali in pazienti con malattia cronica di fegato HBV-correlatain terapia con adefovir |
Proceedings (TIPOLOGIA NON ATTIVA) |
Vai |
| 2005 |
Valutazione della clearance di HCV-RNA sotto trattamento antivirale con Transcription-Mediated Amplification (TMA) |
Proceedings (TIPOLOGIA NON ATTIVA) |
Vai |
| 2005 |
Acute polymyositis during treatment of acute hepatitis C with pegylated interferon alpha-2b |
Articolo in rivista |
Vai |
| 2005 |
RUOLO DELL’INFEZIONE OCCULTA DA HBV NEL PAZIENTE IMMUNOCOMPROMESSO |
Proceedings (TIPOLOGIA NON ATTIVA) |
Vai |
| 2005 |
Prolonged prothrombin time, Factor VII and activated FVII levels in chronic liver disease are partly dependent on Factor VII gene polymorphisms |
Articolo in rivista |
Vai |
| 2005 |
Treatment of hepatitis C: critical appraisal of the evidence |
Articolo in rivista |
Vai |
| 2004 |
Peginterferon alfa-2b plus ribavirin for naive patients with genotype 1 chronic hepatitis C: a randomized controlled trial |
Articolo in rivista |
Vai |
| 2004 |
Effect of peginterferon alfa-2a on liver histology in chronic hepatitis C: a meta-analysis of individual patient data |
Articolo in rivista |
Vai |
| 2004 |
Characteristics of liver cirrhosis in Italy: results from a multicenter national study |
Articolo in rivista |
Vai |
| 2004 |
Percutaneous radiofrequency therma ablation of small hepatocellular carcinoma: a prospective study |
Proceedings (TIPOLOGIA NON ATTIVA) |
Vai |
| 2004 |
Hepatitis B virus reactivation and alemtuzumab therapy |
Proceedings (TIPOLOGIA NON ATTIVA) |
Vai |
| 2004 |
A woman with a long history of abdominal pain |
Articolo in rivista |
Vai |
| 2004 |
Oral lichen planus, hepatitis C virus, and HIV: no association in a cohort study from an area of high hepatitis C virus endemicity |
Articolo in rivista |
Vai |
| 2004 |
Emocromatosi |
Articolo in rivista |
Vai |
| 2004 |
Patologie da sovraccarico di ferro:recenti acquisizioni |
Articolo in rivista |
Vai |
| 2004 |
The aetiological pattern of hepatocellular carcinoma ( HCC) in Italy is changing |
Abstract in rivista |
Vai |
| 2004 |
Hepatitis B virus maintains its pro-oncogenic properties in the case of occult HBV infection |
Articolo in rivista |
Vai |
| 2004 |
UNRESECTABLE HEPATOCELLULAR CARCINOMA:META-ANALYSIS OD ARTERIAL EMBOLIZATION |
Articolo in rivista |
Vai |
| 2004 |
HCV infection and oral lichen planus: a weak association when HCV is endemic |
Articolo in rivista |
Vai |
| 2004 |
The rational use of albumin in patients with cirrhosis and ascites. A Delphi study for the attainment of a consensus on prescribing standards |
Articolo in rivista |
Vai |
| 2004 |
The aetiology of chronic hepatitis in Italy: results from a multicentre national study |
Articolo in rivista |
Vai |
| 2004 |
The impact of antiviral treatments on the course of chronic hepatitis C: an evidence-based approach |
Articolo in rivista |
Vai |
| 2004 |
Oxidative stress inhibits expression of alfa-IFN induced antiviral genes by suppressing tyrosine phosphorylation of Stat-1 in huh 7 cells |
Proceedings (TIPOLOGIA NON ATTIVA) |
Vai |
| 2004 |
Cost Effectiveness of Peginterferon alpha-2a Plus Ribavirin versus Interferon alpha-2b Plus Ribavirin as Initial Therapy for Treatment-Naive Chronic Hepatitis C |
Articolo in rivista |
Vai |
| 2004 |
Preoperative chemoradiotherapy for oesophageal cancer: a systematic review and meta-analysis |
Articolo in rivista |
Vai |
| 2004 |
Clinical outcome of HBeAg-negative chronic hepatitis B in relation to virological response to lamivudine |
Articolo in rivista |
Vai |
| 2004 |
Early virologic response with pegylated interferons |
Articolo in rivista |
Vai |
| 2004 |
HVR-1 quasispecies modifications occur early and are correlated to initial but not sustained response in HCV-infected patients treated with pegylated- or standard-interferon and ribavirin |
Articolo in rivista |
Vai |
| 2004 |
Cost-effectiveness of combination peginterferon alpha-2a and ribavirin compared with interferon alpha-2b and ribavirin in patients with chronic hepatitis C |
Articolo in rivista |
Vai |
| 2004 |
Interferon therapy: the other face of the medal. Ann Ital Med Int. 2004;19(1):5-7. |
Articolo in rivista |
Vai |
| 2003 |
ISDR pattern and evolution in patients with chronic hepatitis C treated with standard or PEG-IFN plus ribavirin |
Articolo in rivista |
Vai |
| 2003 |
A patient with acute hepatitis C and possible IFN toxicity [2] |
Articolo in rivista |
Vai |
| 2003 |
Heterogeneity of HVR-1 quasispecies is predictive of early but not sustained virological response in genotype 1b-infected patients undergoing combined treatment with PEG- or STD-IFN plus RBV |
Articolo in rivista |
Vai |
| 2003 |
Expression of cytokeratin 7 and 20 in pathological conditions of the bile tract |
Articolo in rivista |
Vai |
| 2003 |
Clinical trial results of peginterferons in combination with ribavirin |
Abstract in rivista |
Vai |
| 2003 |
Occult HBV infection and suppression of HCV replication in the early phase of combination therapy for chronic hepatitis C |
Articolo in rivista |
Vai |
| 2003 |
When and how to treat acute hepatitis C? |
Articolo in rivista |
Vai |
| 2003 |
IL-10 and TNF-α polymorphisms and the recovery from HCV infection |
Articolo in rivista |
Vai |
| 2002 |
Endemic hepatitis C virus infection in a Sicilian town: Further evidence for iatrogenic transmission |
Articolo in rivista |
Vai |
| 2002 |
Anti-hepatitis A virus seroprevalence and seroconversion in a cohort of patients with chronic viral hepatitis |
Articolo in rivista |
Vai |
| 2002 |
Early viral clearance and sustained response in chronic hepatitis C: a controlled trial of interferon and ribavirin after high-dose interferon induction |
Articolo in rivista |
Vai |
| 1979 |
ATTUALI ORIENTAMENTI NELLA DIAGNOSTICA DELLA MALATTIA DI HIRSCHSPRUNG |
Articolo in rivista |
Vai |
